Financials
- Market Capitalization 3.49 B
- Employee 601
- Founded 2015
- CEO -
- Website www.arcusbio.com
- Headquarter Delaware, United States
- FIGI BBG00DQD26W3
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-6.81
Relación precio/flujo de caja
9.87
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1587 | DNLI Denali Therapeutics Inc. - Common Stock | 22.97 USD | +1.41% | -10.69% | +3.84% | +42.05% | 3.65 B USD | ||
| 1597 | GPCR Structure Therapeutics Inc - American Depositary Shares | 48.76 USD | -3.62% | -8.52% | +14.17% | +82.35% | 3.47 B USD | ||
| 1608 | ADPT Adaptive Biotechnologies Corporation - Common Stock | 22.56 USD | +5.27% | +13.65% | +39.60% | +30.71% | 3.61 B USD | ||
| 1610 | ARQT Arcutis Biotherapeutics, Inc. - Common stock | 27.75 USD | +3.51% | -0.89% | +8.10% | +78.46% | 3.47 B USD |